• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.

作者信息

Bongiorno Maria Rita, Crimi Nunzio, Corrao Salvatore, Allotta Alberto, Arena Antonino, Brusca Ignazio, Heffler Enrico, Malara Giovanna, Milioto Mirella, Pistone Giuseppe, Porto Morena, Raia Emilio, Valenti Giuseppe

机构信息

Unità Operativa Complessa di Dermatologia e Malattie Sessualmente Trasmesse, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Italy.

Allergologia e Immunologia Clinica, Università di Catania, Dipartimento di Medicina Clinica e Sperimentale, Policlinico Vittorio Emanuele, Catania, Italy.

出版信息

Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6.

DOI:10.1016/j.anai.2016.08.006
PMID:27720581
Abstract
摘要

相似文献

1
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.奥马珠单抗在临床实践中治疗慢性自发性荨麻疹
Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6.
2
Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria.
Ann Allergy Asthma Immunol. 2016 Nov;117(5):559-561. doi: 10.1016/j.anai.2016.08.020. Epub 2016 Oct 24.
3
Home self-administration of omalizumab for chronic spontaneous urticaria.奥马珠单抗用于慢性自发性荨麻疹的家庭自我给药。
Br J Dermatol. 2016 Dec;175(6):1405-1407. doi: 10.1111/bjd.15074. Epub 2016 Oct 27.
4
Chronic spontaneous urticaria in an 8-year-old girl treated with omalizumab.
Clin Exp Dermatol. 2016 Dec;41(8):929-930. doi: 10.1111/ced.12922. Epub 2016 Oct 20.
5
Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South Spain.奥马珠单抗在西班牙南部日常临床实践中治疗慢性自发性荨麻疹的应用
Dermatol Ther. 2018 Sep;31(5):e12669. doi: 10.1111/dth.12669. Epub 2018 Jul 31.
6
Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.奥马珠单抗长期治疗难治性慢性自发性荨麻疹：真实病例经验
Ann Allergy Asthma Immunol. 2015 Dec;115(6):536. doi: 10.1016/j.anai.2015.09.012.
7
Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.使用奥马珠单抗治疗荨麻疹的临床管理：首个获批用于慢性自发性荨麻疹的生物疗法。
J Eur Acad Dermatol Venereol. 2016 Jul;30 Suppl 5:25-32. doi: 10.1111/jdv.13697.
8
IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria.在慢性自发性荨麻疹患者中，奥马珠单抗治疗的应答者的IgE和D-二聚体基线水平高于无应答者。
Br J Dermatol. 2018 Sep;179(3):776-777. doi: 10.1111/bjd.16593. Epub 2018 Jun 26.
9
Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.使用奥马珠单抗或环孢素治疗难治性慢性自发性荨麻疹。
Ann Allergy Asthma Immunol. 2017 Nov;119(5):397-401. doi: 10.1016/j.anai.2017.07.029.
10
Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria.奥马珠单抗治疗一名8岁患有糖尿病和难治性慢性自发性荨麻疹的男孩
J Investig Allergol Clin Immunol. 2019 Apr;29(2):144-146. doi: 10.18176/jiaci.0351.

引用本文的文献

1
The relationship between Fc epsilon receptor-1α and β ( and ) gene polymorphisms in patients with chronic urticaria using omalizumab.使用奥马珠单抗治疗的慢性荨麻疹患者中Fcε受体-1α和β（及）基因多态性之间的关系
Postepy Dermatol Alergol. 2024 Aug;41(4):357-363. doi: 10.5114/ada.2024.142285. Epub 2024 Aug 14.
2
The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria.韩国成人及儿童慢性自发性荨麻疹的KAAACI/KDA循证实践指南：第2部分。H1抗组胺药难治性慢性荨麻疹的管理。
Allergy Asthma Immunol Res. 2020 Sep;12(5):750-770. doi: 10.4168/aair.2020.12.5.750.
3
Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America.
从拉丁美洲使用奥马珠单抗治疗慢性荨麻疹的实际经验中获得的认识。
World Allergy Organ J. 2019 Feb 23;12(2):100011. doi: 10.1016/j.waojou.2019.100011. eCollection 2019.
4
Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria.前沿：慢性自发性荨麻疹的生物标志物。
J Immunol Res. 2018 Nov 21;2018:5615109. doi: 10.1155/2018/5615109. eCollection 2018.
5
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.奥马珠单抗治疗青少年和成人慢性特发性（自发性）荨麻疹患者的获益和危害：“真实世界”证据的荟萃分析。
JAMA Dermatol. 2019 Jan 1;155(1):29-38. doi: 10.1001/jamadermatol.2018.3447.
6
Omalizumab for urticaria treatment in clinical practice: a case series.奥马珠单抗在临床实践中治疗荨麻疹：病例系列
Postepy Dermatol Alergol. 2018 Aug;35(4):372-374. doi: 10.5114/ada.2018.77666. Epub 2018 Aug 21.
7
Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.奥马珠单抗在美国慢性特发性/自发性荨麻疹患者中的实际应用。
Allergy Asthma Proc. 2018 May 7;39(3):191-200. doi: 10.2500/aap.2018.39.4132. Epub 2018 Feb 19.
8
Urticaria and Angioedema: an Update on Classification and Pathogenesis.荨麻疹和血管性水肿：分类和发病机制的更新。
Clin Rev Allergy Immunol. 2018 Feb;54(1):88-101. doi: 10.1007/s12016-017-8628-1.